Tag: Weight Loss
Liraglutide Exerts Weight Loss-Independent, GLP-1R-Dependent Effects
Prior to weight loss, liraglutide improves insulin sensitivity; reductions in fasting and postprandial glucose also seen
FDA Finds No Evidence Linking Wegovy, Ozempic to Suicidal Behaviors
However, the agency noted officials cannot rule out that 'a small risk may exist,' and it will continue to investigate
Prevalence of Weight Loss Product Use 5.5 Percent in Teens
Prevalence ranged from 2.0 percent in past week to 8.9 percent in lifetime; use was higher among girls than boys
Risk for Suicidal Ideation Not Increased With Semaglutide
No increased risk for suicidal ideation seen with semaglutide versus non-GLP1R agonist antiobesity medications
New Side Effects Reported for GLP-1 RA Weight-Loss Drugs
FDA is investigating reports of hair loss, aspiration, and suicidal thoughts among people taking the medications
One-Third of Patients Persist on Antiobesity Medications at Six Months
Semaglutide associated with the highest persistence at one year
Quality of Low-Carb Diets Affects Weight Change in U.S. Adults
Weight gain seen in association with animal and unhealthy low-carb diets; weight loss linked to vegetable, healthy low-carb diets
FDA Warns of Counterfeit Ozempic
New Poll Finds Older Americans Believe Medicare Should Cover Weight-Loss Drugs
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss
USPSTF Recommends Behavioral Interventions for Pediatric Weight Loss
Intensive behavioral interventions recommended for children and teens aged older than 6 years with high BMI
